Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133581) titled 'Remote, Continuous, Non-Invasive Monitoring and Diagnosis of Renal Function Using a Novel Wearable NH3 Sensor' on Sept. 29.

Study Type: Diagnostic test

Study Design: Sequential

Primary Sponsor: Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Condition: N/A

Intervention: Gold Standard:Use blood creatinine as the gold standard for diagnosis, and glomerular filtration rate as the staging diagnostic criterion.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-06-07

Target Sample Size: Target condition:395;Difficult condition:0

Countries of Recru...